Sfda
Drug Stores & Pharmacies · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Geneva, Geneva, 1211, SwitzerlandWebsite
www.swiss-fda.comRevenue
$5.3 MillionIndustry
About Sfda
Sfda Org Chart
Is Sfda your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Sfda is spiking on competitors!
Sfda, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Sfda has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sfda had a recent Job posting/layoffs
Earning: See what the market has to say on Sfda recently announced quarterly report
Funding: Get notified immidiatlly once Sfda has new funding data
Congratulate Masked Content for being promoted to Masked Content at Sfda
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Sfda launches new products
Recommended Actions
Reach out to Masked Content who joined Sfda as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Sfda is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Sfda is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Sfda.
Sfda Tech Stack
A closer look at the technologies used by Sfda
Sfda News & Media
Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the Saudi Food and Drug Authority (SFDA) granted Marketing Authorization for CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited therapy, for the treatment of sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). CASGEVY is approved for the treatment of people 12 years of age and older with SCD or TDT. The Kingdom of Saudi Arabia has among the highest preva
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sfda
SFDA SA, a Swiss company headquartered in Geneva, is leader in sourcing and trading of pharmaceutical, medical products & devices, hospital disposables, hi-tech equipment from and to any part of the world. We supply a wide range of Swiss and international medicinal and wide range of healthcare products to all authorized professionals, companies, ho... Read More